Clinical Trial Matcher

NCT06393543

International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

Not Yet Recruiting · Not specified · Radboud University Medical Center · registry updated 2024-05-01

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

To prospectively assess the incidence of peritoneal carcinomatosis for women with isolated STIC (serous tubal intraepithelial carcinoma). Moreover, to identify histopathological characteristics of STIC which are reproducible and associated to the risk of peritoneal carcinomatosis and to report the findings of additional diagnostics.

Inclusion

  • Bilateral salpingectomy (with or without oophorectomy)
  • A serous tubal intraepithelial carcinoma at histopathological review

Exclusion

  • Invasive cancer at initial surgery or pathological examination (either macroscopic and/or microscopic)

Open NCT06393543 on ClinicalTrials.govAll conditions